Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Getting in on the ground floor would be great, but only if there's massive upside ahead for the company. Several stocks on the market offer investors the opportunity to capitalize on the rapidly ...

When Quincy Mayor Thomas Koch talks about the controversial Catholic statues he ordered for the city’s new police and fire headquarters — without public input — he still seems surprised at the ...

Ilse Koch was a German war criminal who allegedly used human remains to make household objects Caroline Blair is a writer for PEOPLE. She has been writing about celebrities, entertainment, reality TV ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Monster: Ed Gein Story is currently airing on Netflix, looking into the vile crimes of Gein - also known as the Butcher of Plainfield. For years, experts have speculated about what drove Ed Gein to ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...

Denise Koch has served as a news anchor and reporter at WJZ-TV for more than 40 years, establishing herself as one of Maryland’s most recognizable and trusted journalism voices. Throughout her ...

Cooper Koch quickly rose to prominence thanks to his breakout role in Netflix’s anthology series Monsters: The Lyle an Erik Menendez Story. The Los Angeles-born actor portrayed Erik Menéndez, one of ...